Every approved GLP-1 label says to come off the drug ahead of a planned pregnancy: animal studies show harm to the fetus and the human evidence is thin. Several also warn that a slowed stomach can interfere with how well the contraceptive pill is absorbed — which is the part most likely to matter to someone who is not planning anything.
Stopping before conception
| Drug | Roughly how long it lingers | What the label asks |
|---|---|---|
| Wegovy / Ozempic (semaglutide) | About a week | Stop a full two months ahead of a planned pregnancy. This is the one written explicitly into a label. |
| Zepbound / Mounjaro (tirzepatide) | About five days | Stop as soon as a pregnancy is known about; not for use during pregnancy. |
| Saxenda (liraglutide) | About 13 hours | Stop when pregnancy is recognized. Clears in days rather than months, but still plan it with your prescriber. |
| Foundayo (orforglipron) | About a day | Stop when pregnancy is recognized; discuss any plan beforehand. |
The two-month figure for semaglutide is not arbitrary — it reflects how long the drug takes to clear properly after a final dose. Every other row is a reference point rather than a rule, and the decision belongs with your prescriber, ideally alongside a maternal-fetal medicine specialist.
The contraception warning people miss
⚠ This is the most actionable thing on the page. The Zepbound label tells anyone relying on the contraceptive pill to move onto a method that is not swallowed, or to pair it with a barrier method, across four weeks from the start and four weeks from each increase thereafter.
Read that second half again. On a ladder with five increases, that is five separate four-week stretches where the pill alone may not be doing what you think it is. It is easy to hear the warning once, at the start, and never apply it again.
- Why: these drugs slow the stomach, and the effect is sharpest right after starting and right after each step up — exactly when absorption of a swallowed tablet is least predictable.
- What sidesteps it entirely: anything not swallowed. Coils, implants, injections, the patch, the ring.
- This is label text, not folklore. Ask your prescriber which method suits you while you are titrating.
If you are already pregnant
- Do not panic. The labels say to stop. None of them describes an exposure as grounds for ending a pregnancy, and findings in animals do not transfer one-to-one to people.
- Write down the timeline — date of last injection, the dose, how many weeks along you were, anything else you take. That is what the specialist team needs.
- Stop the GLP-1. Carry on with prenatal vitamins, folate and everything obstetric.
- Ask for a maternal-fetal medicine referral. Counseling and any extra scanning happen there rather than in primary care.
- Consider the manufacturers' pregnancy registries. They enroll exposed pregnancies specifically to build the human record that does not yet exist. Your exposure could inform the advice given to someone else.
Breastfeeding
The honest answer is that nobody knows. None of these labels can say whether the drug appears in human milk, what it might do to a nursing infant, or whether it affects supply, because the studies have not been done. Semaglutide was detected in the milk of rats, which is what drives the cautious wording without establishing human risk.
That leaves a genuine judgment call rather than a rule, and it is one to make with both your prescriber and a lactation specialist rather than from a page like this one.
The unplanned pregnancies
The stories about surprise conceptions on these drugs are mostly not a mystery, and mostly not a direct drug effect on ovulation. They are a consequence of weight loss.
In polycystic ovary syndrome, losing 5 to 10% of your body weight restores ovulation in a meaningful share of people — and losing 5 to 10% is precisely what these drugs do reliably. Someone who had not been ovulating, and therefore had not needed contraception, may now need it. Layer the pill-absorption issue on top and the two effects compound.
If you have PCOS and are starting one of these, that is worth a conversation before rather than after.
Call the specialist team if
- A pregnancy test is positive while you are on the drug. Stop it and ring your prescriber the same day.
- Severe sickness in early pregnancy after recent exposure. Hyperemesis plus a drug that slows the stomach needs seeing in person, not a message.
- Bleeding, severe abdominal pain, or dehydration in any exposed pregnancy.
- Anything unexpected on a first-trimester screen or anatomy scan where there was exposure — route that to maternal-fetal medicine.
- You are breastfeeding and someone wants to restart the drug. That needs both your prescriber and a lactation specialist.
What this does not cover
- Fertility treatment. IVF and IUI clinics set their own washout windows and they are often stricter than the insert. Ask that team directly.
- Compounded GLP-1s, which have no pregnancy or lactation data whatsoever. Reasoning across from a brand label is guesswork, not extrapolation.
- Managing diabetes in pregnancy, which belongs with endocrinology and maternal-fetal medicine.
Where to go next
- Pregnancy and conception in full — the evidence behind these rules at proper length.
- GLP-1s and hormonal birth control — the absorption mechanism explained.
- All cheat sheets — the full reference library.
- Sick-day guide — where dehydration and pregnancy risk overlap.